These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 6348504)

  • 21. Type I Interferon Counters or Promotes Coxiella burnetii Replication Dependent on Tissue.
    Hedges JF; Robison A; Kimmel E; Christensen K; Lucas E; Ramstead A; Jutila MA
    Infect Immun; 2016 Jun; 84(6):1815-1825. PubMed ID: 27068091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viable Coxiella burnetii Induces Differential Cytokine Responses in Chronic Q Fever Patients Compared to Heat-Killed Coxiella burnetii.
    Jansen AFM; Dinkla A; Roest HJ; Bleeker-Rovers CP; Schoffelen T; Joosten LAB; Wever PC; van Deuren M; Koets AP
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30037794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Splenomegaly, sex, and other characteristics of laboratory animals used for primary isolations of Coxiella burnetii.
    Franti CE; Behymer DE; Goggin JE; Wright ME
    Lab Anim Sci; 1974 Aug; 24(4):656-65. PubMed ID: 4369207
    [No Abstract]   [Full Text] [Related]  

  • 24. Coxiella burnetii infection in C57BL/6 mice aged 1 or 14 months.
    Leone M; Bechah Y; Meghari S; Lepidi H; Capo C; Raoult D; Mege JL
    FEMS Immunol Med Microbiol; 2007 Aug; 50(3):396-400. PubMed ID: 17555529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein array of Coxiella burnetii probed with Q fever sera.
    Wang X; Xiong X; Graves S; Stenos J; Wen B
    Sci China Life Sci; 2013 May; 56(5):453-9. PubMed ID: 23633077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR2 is necessary to inflammatory response in Coxiella burnetii infection.
    Meghari S; Honstettre A; Lepidi H; Ryffel B; Raoult D; Mege JL
    Ann N Y Acad Sci; 2005 Dec; 1063():161-6. PubMed ID: 16481508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity in Q fever.
    Kazár J
    Acta Virol; 1988 Jul; 32(4):358-68. PubMed ID: 2903642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.
    Shannon JG; Heinzen RA
    Immunol Res; 2009; 43(1-3):138-48. PubMed ID: 18813881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of B cells in host defense against primary Coxiella burnetii infection.
    Schoenlaub L; Elliott A; Freches D; Mitchell WJ; Zhang G
    Infect Immun; 2015 Dec; 83(12):4826-36. PubMed ID: 26438792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variation in TLR10 is not associated with chronic Q fever, despite the inhibitory effect of TLR10 on Coxiella burnetii-induced cytokines in vitro.
    Ammerdorffer A; Stappers MH; Oosting M; Schoffelen T; Hagenaars JC; Bleeker-Rovers CP; Wegdam-Blans MC; Wever PC; Roest HJ; van de Vosse E; Netea MG; Sprong T; Joosten LA
    Cytokine; 2016 Jan; 77():196-202. PubMed ID: 26364993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host--implications for post Q fever infection fatigue syndrome and other chronic sequelae.
    Marmion BP; Sukocheva O; Storm PA; Lockhart M; Turra M; Kok T; Ayres J; Routledge H; Graves S
    QJM; 2009 Oct; 102(10):673-84. PubMed ID: 19556396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SCID mouse model for lethal Q fever.
    Andoh M; Naganawa T; Hotta A; Yamaguchi T; Fukushi H; Masegi T; Hirai K
    Infect Immun; 2003 Aug; 71(8):4717-23. PubMed ID: 12874353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biogenesis of the lysosome-derived vacuole containing Coxiella burnetii.
    Kohler LJ; Roy CR
    Microbes Infect; 2015; 17(11-12):766-71. PubMed ID: 26327296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of cynomolgus (Macaca fascicularis) and rhesus (Macaca mulatta) monkeys as experimental models of acute Q fever after aerosol exposure to phase-I Coxiella burnetii.
    Waag DM; Byrne WR; Estep J; Gibbs P; Pitt ML; Banfield CM
    Lab Anim Sci; 1999 Dec; 49(6):634-8. PubMed ID: 10638499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of
    Sobotta K; Hillarius K; Jiménez PH; Kerner K; Heydel C; Menge C
    Front Cell Infect Microbiol; 2017; 7():543. PubMed ID: 29379776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens.
    Izzo AA; Marmion BP; Hackstadt T
    Clin Exp Immunol; 1991 Jul; 85(1):98-108. PubMed ID: 2070564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Early Stages of Human Alveolar Infection by the Q Fever Agent
    Dragan AL; Kurten RC; Voth DE
    Infect Immun; 2019 Mar; 87(5):. PubMed ID: 30833339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental infection of hare (Lepus europaeus) with Coxiella burnetii and Rickettsia slovaca.
    Rehácek J; Urvölgyi J; Brezina R; Kazár J; Kovácová E
    Acta Virol; 1978 Sep; 22(5):417-25. PubMed ID: 30267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both Major Histocompatibility Complex Class I (MHC-I) and MHC-II Molecules Are Required, while MHC-I Appears To Play a Critical Role in Host Defense against Primary Coxiella burnetii Infection.
    Buttrum L; Ledbetter L; Cherla R; Zhang Y; Mitchell WJ; Zhang G
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Attenuated variants of Rickettsia burneti and several prospects for their use in live vaccines against Q fever].
    Urakov NN; Gudima OS; Tereshchenko MO; Shchetinin VP; Shevyreva NA
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Feb; 43(2):143. PubMed ID: 6004845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.